Chesterfield, MO, United States of America

Satish Singh

This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Satish Singh. Retrieved from https://idiyas.com/inventor/satish-singh-97wil3f2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Satish Singh

Introduction

Satish Singh is an accomplished inventor based in Chesterfield, MO (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody compositions. His work focuses on innovative solutions for treating various diseases and conditions.

Latest Patents

Satish Singh holds 1 patent for his invention titled "Anti-CTLA-4 antibody compositions." This patent provides novel compositions of anti-CTLA-4 antibodies that include a chelating agent. The invention also outlines methods for treating diseases and conditions associated with CTLA-4 antibodies, including various neoplasia conditions.

Career Highlights

Satish Singh is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative therapies.

Collaborations

Throughout his career, Satish has collaborated with notable colleagues, including Justin Abate and Kevin Muthurania. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Satish Singh's contributions to the field of biotechnology exemplify the impact of innovative thinking in medicine. His work on anti-CTLA-4 antibody compositions showcases the potential for new treatments in combating serious health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…